ARGININE-INDUCED INSULIN RELEASE IN GLUCOKINASE-DEFICIENT SUBJECTS

被引:14
|
作者
PUEYO, ME
CLEMENT, K
VAXILLAIRE, M
PASSA, P
FROGUEL, P
ROBERT, JJ
VELHO, G
机构
[1] HOP ST LOUIS,INSERM,U358,LGM,F-75010 PARIS,FRANCE
[2] HOP ST LOUIS,DEPT ENDOCRINOL,F-75010 PARIS,FRANCE
[3] CEPH,CTR HUMAN POLYMORPHISM STUDY,PARIS,FRANCE
[4] HOP NECKER ENFANTS MALAD,INSERM,U367,PARIS,FRANCE
[5] HOP NECKER ENFANTS MALAD,INSERM,U30,PARIS,FRANCE
关键词
D O I
10.2337/diacare.17.9.1015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- In eight glucokinase (GCK)-deficient subjects, we have investigated insulin secretion rates (ISRs) in response to intravenous arginine. Impairment in the enzymatic activity of mutant GCK leads to a reduced glycolytic flux in p-cells. This defect translates in vivo as a right shift in the glucose/ISR dose-response curve. Insulin secretion in response to other secretagogues has not been reported. RESEARCH DESIGN AND METHODS- The arginine test was performed immediately after a 2-h hyperglycemic (10 mM) clamp. ISR was computed by deconvolution of peripheral C-peptide levels. Linear regression analyses were performed to assess correlations between the beta-cell secretory responses to the arginine test, an intravenous glucose tolerance test (IVGTT), and a hyperglycemic clamp (areas under the C-peptide curves), and between these parameters and the glucose tolerance status (area under the glucose curve during an oral glucose tolerance test). RESULTS- Two minutes after the injection of arginine, the increment in ISR was 30.17 +/- 10.01 pmol insulin.kg(-1) min(-1) in patients and 36.25 +/- 15.46 pmol insulin.kg(-1) min(-1) in control subjects (P = 0.38). Throughout the experiment, increments in ISR were comparable in both groups. The amount of insulin secreted in response to arginine (0-5 min) was similar in patients and control subjects: 81 +/- 28 vs. 119 +/- 55 pmol/kg (P = 0.16), respectively. The arginine test C-peptide response was not correlated with the IVGTT or hyperglycemic clamp responses. The arginine test and hyperglycemic clamp responses were not correlated to the glucose tolerance status. The best predictor of the glucose tolerance was the C-peptide response to the IVGTT (r(2) = 0.78; P = 0.002). CONCLUSIONS- beta-cell secretory increment in response to arginine was found le be in the normal range in GCK-deficient subjects. The arginine test does not seem to reflect either the beta-cell secretory defect or the glucose tolerance status of these subjects. IVGTT seems to be the best predictor of the latter parameter in this population.
引用
收藏
页码:1015 / 1021
页数:7
相关论文
共 50 条
  • [41] Effects of Liraglutide on β-Cell-Specific Glucokinase-Deficient Neonatal Mice
    Shirakawa, Jun
    Tanami, Ritsuko
    Togashi, Yu
    Tajima, Kazuki
    Orime, Kazuki
    Kubota, Naoto
    Kadowaki, Takashi
    Goshima, Yoshio
    Terauchi, Yasuo
    ENDOCRINOLOGY, 2012, 153 (07) : 3066 - 3075
  • [42] GLUCOKINASE INHIBITION DIFFERENTIALLY AFFECTS INSULIN RELEASE BY GLUCOSE AND ARGININE INVIVO
    BALKAN, B
    DUNNING, BE
    DIABETOLOGIA, 1992, 35 : A29 - A29
  • [43] EVIDENCE FOR INSULIN INVOLVEMENT IN ARGININE-INDUCED AND GLUCOSE-INDUCED HYPERCALCIURIA IN THE RAT
    WOOD, RJ
    ALLEN, LH
    JOURNAL OF NUTRITION, 1983, 113 (08): : 1561 - 1567
  • [44] EFFECT OF BICARBONATE ON THE ARGININE-INDUCED INSULIN AND GLUCAGON-SECRETION INVITRO
    CAMPILLO, JE
    LUYCKX, AS
    LEFEBVRE, PJ
    HORMONE AND METABOLIC RESEARCH, 1981, 13 (10) : 552 - 556
  • [45] DEFECTIVE ARGININE-INDUCED INSULIN-SECRETION IN CHILDREN WITH NUTRITIONAL RICKETS
    SOLIMAN, ATM
    AREF, MK
    HASSAN, AEI
    ANNALS OF SAUDI MEDICINE, 1989, 9 (03) : 254 - 258
  • [46] DISSOCIATED EFFECTS OF SOMATOSTATIN ANALOGS ON ARGININE-INDUCED INSULIN, GLUCAGON AND GROWTH-HORMONE RELEASE IN ACROMEGALIC PATIENTS
    WAJCHENBERG, BL
    CESAR, FP
    LEME, CE
    BORGHI, VC
    SOUZA, ITT
    NETO, DG
    GERMEK, OA
    COY, DH
    COMARUSCHALLY, AM
    SCHALLY, AV
    HORMONE AND METABOLIC RESEARCH, 1983, 15 (10) : 471 - 474
  • [47] ENHANCEMENT OF ARGININE-INDUCED INSULIN SECRETION IN MAN BY PRIOR ADMINISTRATION OF GLUCOSE
    LEVIN, SR
    KARAM, JH
    HANE, S
    GRODSKY, GM
    FORSHAM, PH
    DIABETES, 1971, 20 (03) : 171 - &
  • [48] STIMULUS-SECRETION COUPLING OF ARGININE-INDUCED INSULIN RELEASE - RESISTANCE OF ARGININE-STIMULATED AND ORNITHINE-STIMULATED GLUCAGON AND INSULIN RELEASE TO D,L-ALPHA-DIFLUOROMETHYLORNITHINE
    LECLERCQMEYER, V
    MARCHAND, J
    MALAISSE, WJ
    BIOCHEMICAL PHARMACOLOGY, 1990, 39 (03) : 537 - 547
  • [49] HYPERINSULINEMIA DECREASES 2ND-PHASE BUT NOT FIRST-PHASE ARGININE-INDUCED INSULIN RELEASE IN HUMANS
    PIATTI, PM
    PONTIROLI, AE
    CAUMO, A
    SANTAMBROGIO, G
    MONTI, LD
    COSTA, S
    GARBETTA, F
    BARUFFALDI, L
    COBELLI, C
    POZZA, G
    DIABETES, 1994, 43 (09) : 1157 - 1163
  • [50] CIRCADIAN CHANGES IN BIPHASIC PATTERN OF ARGININE-INDUCED INSULIN-SECRETION
    CAPANI, F
    ANGELUCCI, E
    BASILICO, L
    CONSOLI, A
    NUZZO, A
    SENSI, S
    DIABETOLOGIA, 1982, 23 (03) : 294 - 294